Back to Monographs
ingredients

Babassu (Orbignya phalerata)

Background

  • The babassu (Orbignya phalerata) is a native tree of the Arecaceae (Palmae) family from northern Brazil. Extract of the babassu coconut has been widely used as a food source. As a medicinal product, it is known for its wound healing, fever-reducing, blood thinning, thyroid-regulating, and anti-inflammatory properties.
  • Babassu coconut (mesocarp) has been widely used as a treatment of pain, fever, constipation, obesity, leukemia, rheumatism, ulcerations, tumors, wounds, and inflammation.

References

Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to . Selected references are listed below.

  • Amorim E, Matias JE, Coelho JC, et al. [Topic use of aqueous extract of Orbignya phalerata (babassu) in rats: analysis of its healing effect]. Acta Cir.Bras. 2006;21 Suppl 2:67-76.
    View Abstract
  • Azevedo AP, Farias JC, Costa GC, et al. Anti-thrombotic effect of chronic oral treatment with Orbignya phalerata Mart. J Ethnopharmacol 4-20-2007;111(1):155-159.
    View Abstract
  • Baldez RN, Malafaia O, Czeczko NG, et al. [Healing of colonic anastomosis with the use of extract aqueous of Orbignya phalerata (Babassu) in rats]. Acta Cir.Bras. 2006;21 Suppl 2:31-38.
    View Abstract
  • Batista CP, Torres OJ, Matias JE, et al. [Effect of watery extract of Orbignya phalerata (babassu) in the gastric healing in rats: morphological and tensiometric study]. Acta Cir.Bras. 2006;21 Suppl 3:26-32.
    View Abstract
  • Brito Filho SB, Matias JE, Stahlke Junior HJ, et al. [Analysis of healing in the Alba Linea with the use of Orbignya phalerata (babassu) water extract. Controlled study in rats]. Acta Cir.Bras. 2006;21 Suppl 3:76-88.
    View Abstract
  • da Silva BP, Parente JP. An anti-inflammatory and immunomodulatory polysaccharide from Orbignya phalerata. Fitoterapia 2001;72(8):887-893.
    View Abstract
  • Ferreira Ede C, Matias JE, Campos AC, et al. [Surgical bladder wounds treated with Orbignya phalerata aqueous extract: controlled study in rats]. Acta Cir.Bras. 2006;21 Suppl 3:33-39.
    View Abstract
  • Freire DM, Sant'Anna GL Jr, Alves TL. Mathematical modeling of lipase and protease production by Penicillium restrictum in a batch fermenter. Appl Biochem Biotechnol. 1999;77-79:845-855.
    View Abstract
  • Luz C, Batagin I. Potential of oil-based formulations of Beauveria bassiana to control Triatoma infestans. Mycopathologia 2005;160(1):51-62.
    View Abstract
  • Marques SG, Silva Cde M, Saldanha PC, et al. Isolation of Fonsecaea pedrosoi from the shell of the babassu coconut (Orbignya phalerata Martius) in the Amazon region of Maranhao Brazil. Nippon Ishinkin.Gakkai Zasshi 2006;47(4):305-311.
    View Abstract
  • Martins NL, Malafaia O, Ribas-Filho JM, et al. [Healing process in cutaneous surgical wounds in rats under the influence of Orbignya phalerata aqueous extract]. Acta Cir.Bras. 2006;21 Suppl 3:66-75.
    View Abstract
  • Nascimento FR, Barroqueiro ES, Azevedo AP, et al. Macrophage activation induced by Orbignya phalerata Mart. J Ethnopharmacol 1-3-2006;103(1):53-58.
    View Abstract
  • Oliveira FC, Freire DM, Castilho LR. Production of poly(3-hydroxybutyrate) by solid-state fermentation with Ralstonia eutropha. Biotechnol.Lett 2004;26(24):1851-1855.
    View Abstract
  • Palma MB, Pinto AL, Gombert AK, et al. Lipase production by Penicillium restrictum using solid waste of industrial babassu oil production as substrate. Appl Biochem Biotechnol. 2000;84-86:1137-1145.
    View Abstract
  • Sarubbo LA, Porto AL, Campos-Takaki GM. The use of babassu oil as substrate to produce bioemulsifiers by Candida lipolytica. Can.J Microbiol. 1999;45(5):423-426.
    View Abstract
Disclaimer: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.